HARBIN GLORIA PHARMACEUTICALS Co., LTD announced private placement of A Shares for proceeds of not more than CNY 300,000,000 on May 15, 2023. The transaction will include participation from not more than 35 investors. The issuance price is not less than 80% of the average price in the 20 trading days before the pricing reference date and not more than 30% of total share capital.

The shares cannot be transferred within 6 months from the issuance closing date. The transaction was approved by the shareholder of the company at its 2022 Annual General Shareholders Meeting.